Susan E. Bates
Impact in
- Oncology top 0.01%
- Drug Transport and Resistance Mechanisms
- Cancer Cells and Metastasis
- Cancer Research top 0.1%
Papers in
- Oncology 275
- Drug Transport and Resistance Mechanisms 150
- Pancreatic and Hepatic Oncology Research 29
-
- Histone Deacetylase Inhibitors Research 70
- Cancer therapeutics and mechanisms 52
- Protein Degradation and Inhibitors 28
- Epigenetics and DNA Methylation 27
- Co-authors
- Tito Fojo (98 shared papers)Michael M. Gottesman (11 shared papers)Robert W. Robey (110 shared papers)Michael Dean (15 shared papers)Antonio Tito Fojo (49 shared papers)Thomas Litman (27 shared papers)Richard Piekarz (51 shared papers)Orsolya Polgár (18 shared papers)
- Journals
- Journal of Clinical Oncology (43 papers)Clinical Cancer Research (31 papers)The Oncologist (25 papers)Cancer Research (24 papers)Blood (20 papers)
- Partner nations
- United StatesIsraelUnited Kingdom
In The Last Decade
Susan E. Bates
439 papers receiving 38.0k citations
Susan E. Bates's Hit Papers
Peers
Comparison fields: 5 of 185
- Oncology 21.1k
- Cancer Research 3.8k
- Molecular Biology 18.4k
- Pediatrics, Perinatology and Child Health 3.8k
- Infectious Diseases 2.8k
Countries citing papers authored by Susan E. Bates
This map shows the geographic impact of Susan E. Bates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan E. Bates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan E. Bates more than expected).
Fields of papers citing papers by Susan E. Bates
This network shows the impact of papers produced by Susan E. Bates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan E. Bates. The network helps show where Susan E. Bates may publish in the future.
Co-authors
The 25 scholars most cited alongside Susan E. Bates, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 454 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Multidrug resistance in cancer: role of ATP–dependent transporters Hit paper breakdown → | 2002 | 4574 |
| 2 | Tumour stem cells and drug resistance Hit paper breakdown → | 2005 | 2992 |
| 3 | Revisiting the role of ABC transporters in multidrug-resistant cancer Hit paper breakdown → | 2018 | 1429 |
| 4 | Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Hit paper breakdown → | 1999 | 673 |
| 5 | The Role of ABC Transporters in Clinical Practice Hit paper breakdown → | 2003 | 651 |
| 6 | From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance Hit paper breakdown → | 2001 | 574 |
| 7 | Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma Hit paper breakdown → | 2009 | 568 |
| 8 | 2003 | 487 | |
| 9 | 2000 | 443 | |
| 10 | Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms. | 2002 | 434 |
| 11 | 1988 | 381 | |
| 12 | 1990 | 374 | |
| 13 | 2001 | 366 | |
| 14 | 2008 | 366 | |
| 15 | 2011 | 362 | |
| 16 | Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells. | 2001 | 352 |
| 17 | Epigenetic Therapies for Cancer Hit paper breakdown → | 2020 | 328 |
| 18 | 2007 | 307 | |
| 19 | 2003 | 302 | |
| 20 | 2003 | 302 |
About Susan E. Bates
Susan E. Bates is a scholar working on Oncology, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine and Pediatrics, Perinatology and Child Health, having authored 454 papers that have together received 38.8k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (150 papers), Histone Deacetylase Inhibitors Research (70 papers), Cancer therapeutics and mechanisms (52 papers), Pharmacological Effects and Toxicity Studies (37 papers), Cancer Genomics and Diagnostics (30 papers), Pancreatic and Hepatic Oncology Research (29 papers), Protein Degradation and Inhibitors (28 papers) and Epigenetics and DNA Methylation (27 papers). The work is most often cited by research in Oncology (21.1k citations), Cancer Research (3.8k citations), Molecular Biology (18.4k citations), Pediatrics, Perinatology and Child Health (3.8k citations) and Infectious Diseases (2.8k citations). Susan E. Bates has collaborated with scholars based in United States, Israel and United Kingdom. Frequent co-authors include Tito Fojo, Michael M. Gottesman, Robert W. Robey, Michael Dean, Antonio Tito Fojo, Thomas Litman, Richard Piekarz, Orsolya Polgár, Wilfred D. Stein and Zhirong Zhan. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, The Oncologist, Cancer Research and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.